Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease (Q34113690)

31 July 2017

title

Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease (English)

1 reference

31 July 2017

0 references

1 reference

1 reference

Keisuke Kitakaze

6

0 references

author name string

Takashi Kodama

1

1 reference

31 July 2017

Tadayasu Togawa

2

1 reference

31 July 2017

Takahiro Tsukimura

3

1 reference

31 July 2017

Ikuo Kawashima

4

1 reference

31 July 2017

Kazuhiko Matsuoka

5

1 reference

31 July 2017

Daisuke Tsuji

7

1 reference

31 July 2017

Kohji Itoh

8

1 reference

31 July 2017

Yo-Ichi Ishida

9

1 reference

31 July 2017

Minoru Suzuki

10

1 reference

31 July 2017

Toshihiro Suzuki

11

1 reference

31 July 2017

Hitoshi Sakuraba

12

1 reference

31 July 2017

language of work or name

English

0 references

publication date

20 December 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

e29074

1 reference

Creative Commons Attribution 4.0 International

31 July 2017

copyright license

start time

20 December 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Effective gene therapy in an authentic model of Tay-Sachs-related diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.

5 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029074

Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029074

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029074

Plasma globotriaosylsphingosine as a biomarker of Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029074

Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029074

A sensitive assay of lysogangliosides using high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029074

Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243693

Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis

28 October 2018

1 reference

12 December 2020

A novel missense mutation (C522Y) is present in the beta-hexosaminidase beta-subunit gene of a Japanese patient with infantile Sandhoff disease

1 reference

12 December 2020

Adult Sandhoff's disease: R505Q and I207V substitutions in the HEXB gene of the first Japanese case

1 reference

12 December 2020

GM2 gangliosidosis AB variant: clinical and biochemical studies of a Japanese patient

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0029074

Identifiers

DOI

1 reference

31 July 2017

0 references

1 reference

31 July 2017

1 reference